Literature DB >> 15526354

Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.

Jing-Yuan Fang1, Zhong-Hua Cheng, Ying-Xuan Chen, Rong Lu, Li Yang, Hong-Yin Zhu, Lun-Gen Lu.   

Abstract

AIM: To explore the effect of DNA methyltransferase, demethylase and methyl-CpG binding protein MeCP2 on the expressions and methylation of hMSH2 and proto-oncogene in human gastric cancer.
METHODS: Paired samples of primary gastric cancer and corresponding para-cancerous, non-cancerous gastric mucosae were obtained from surgically resected specimens of 28 patients. Transcription levels of Dnmt1, mbd2, MeCP2, p16(INK4A), hMSH2 and c-myc were detected by using real-time PCR or RT-PCR. Promoter methylation of p16(INK4A), c-myc and hMSH2 genes was assayed by methylation-specific PCR (MSP) and sequencing (mapping). Their relationships were analyzed by Fisher's exact test using the software SPSS.
RESULTS: The average mRNA level of Dnmt1 gene from cancerous tissue was higher and that of mbd2 gene from cancerous tissue was lower than that from non-cancerous tissue, respectively. mbd2 was lower in cancerous tissue than in non-cancerous tissue in 14 (50.0%) of patients but higher in 3 cases (10.7%) of non-cancerous gastric tissue (P<0.001). c-myc expression was up-regulated in cancer tissues (P<0.05). The up-regulation of mbd2 was found in all patients with hypomethylated c-myc. The transcriptional levels of p16(INK4A) and MeCP2 genes did not display any difference between gastric cancerous and matched non-cancerous tissues. There were down-regulation and hypermethylation of hMSH2 in cancer tissues, and the hypermethylation of hMSH2 coexisted with down-regulated transcription. However, the transcription level of the above genes was not associated with biological behaviours of gastric cancers.
CONCLUSION: The up-regulation of proto-oncogene may be the consequence of epigenetic control of gene expression by demethylase, and mbd2 is involved in the regulation of hMSH2 expression in human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526354      PMCID: PMC4576216          DOI: 10.3748/wjg.v10.i23.3394

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Alterations of level of total genomic DNA methylation and pattern of c-myc, c-Ha-ras oncogene methylation in human gastric carcinogenesis.

Authors:  J Fang; S Zhu; S Xiao; Y Shi; S Jiang; X Zhou; L Qian
Journal:  Chin Med J (Engl)       Date:  1996-10       Impact factor: 2.628

2.  Studies on the hypomethylation of c-myc, c-Ha-ras oncogenes and histopathological changes in human gastric carcinoma.

Authors:  J Y Fang; S S Zhu; S D Xiao; S J Jiang; Y Shi; X Y Chen; X M Zhou; L F Qian
Journal:  J Gastroenterol Hepatol       Date:  1996-11       Impact factor: 4.029

3.  Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation.

Authors:  J Y Fang; J A Mikovits; R Bagni; C L Petrow-Sadowski; F W Ruscetti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  A mammalian protein with specific demethylase activity for mCpG DNA.

Authors:  S K Bhattacharya; S Ramchandani; N Cervoni; M Szyf
Journal:  Nature       Date:  1999-02-18       Impact factor: 49.962

5.  Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma.

Authors:  N Oue; H Shigeishi; H Kuniyasu; H Yokozaki; K Kuraoka; R Ito; W Yasui
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

6.  DNA methyltransferase and demethylase in human prostate cancer.

Authors:  Samir K Patra; Aditi Patra; Hong Zhao; Rajvir Dahiya
Journal:  Mol Carcinog       Date:  2002-03       Impact factor: 4.784

7.  The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.

Authors:  Mitsuo Sato; Yoshitsugu Horio; Yoshitaka Sekido; John D Minna; Kaoru Shimokata; Yoshinori Hasegawa
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

8.  Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.

Authors:  Ka-Fai To; Wai K Leung; Tin-Lap Lee; Jun Yu; Joanna H M Tong; Michael W Y Chan; Enders K W Ng; S C Sydney Chung; Joseph J Y Sung
Journal:  Int J Cancer       Date:  2002-12-20       Impact factor: 7.396

9.  MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.

Authors:  Agus Darwanto; Riko Kitazawa; Sakan Maeda; Sohei Kitazawa
Journal:  Cancer Sci       Date:  2003-05       Impact factor: 6.716

10.  MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.

Authors:  H M Müller; H Fiegl; G Goebel; M M Hubalek; A Widschwendter; E Müller-Holzner; C Marth; M Widschwendter
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  15 in total

1.  microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.

Authors:  Zhihong Weng; Dongdong Wang; Wenyue Zhao; Mengqi Song; Faping You; Lian Yang; Libo Chen
Journal:  Exp Ther Med       Date:  2011-06-17       Impact factor: 2.447

Review 2.  Epigenetic effects of ethanol on liver and gastrointestinal injury.

Authors:  Shivendra D Shukla; Annayya R Aroor
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

4.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.

Authors:  E K O Ng; W P Tsang; S S M Ng; H C Jin; J Yu; J J Li; C Röcken; M P A Ebert; T T Kwok; J J Y Sung
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

Review 5.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 6.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Expression of DNMTs and MBD2 in GIST.

Authors:  Miao He; Jing Fan; Rong Jiang; Wei-Xue Tang; Zi-Wei Wang
Journal:  Biomed Rep       Date:  2012-10-29

8.  The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.

Authors:  Wen-Jin Ding; Jing-Yuan Fang; Xiao-Yu Chen; Yan-Shen Peng
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

Review 9.  Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome.

Authors:  Michael J Meaney; Moshe Szyf
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

10.  MYC deregulation in gastric cancer and its clinicopathological implications.

Authors:  Carolina Rosal Teixeira de Souza; Mariana Ferreira Leal; Danielle Queiroz Calcagno; Eliana Kelly Costa Sozinho; Bárbara do Nascimento Borges; Raquel Carvalho Montenegro; Andrea Kely Campos Ribeiro Dos Santos; Sidney Emanuel Batista Dos Santos; Helem Ferreira Ribeiro; Paulo Pimentel Assumpção; Marília de Arruda Cardoso Smith; Rommel Rodríguez Burbano
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.